In the News

Memory Health Formulation Featured in New Study on Improving Mild Cognitive Impairment (MCI)

The Lab Report Podcast: Connecting Lab Testing with Personalized Medicine and Optimized Health

Complementary & Alternative Medicine Market Worth $296.3 Billion by 2027: Grand View Research, Inc.

Landmark Study Published in Nature Medicine and Presented at the American Society of Nutrition Shows Dietary Inflammation Varies Dramatically Among Healthy Adults, Pointing to the Need for Personalization in Eating

Memory Health Formulation Featured in New Study on Improving Mild Cognitive Impairment (MCI)

The Nutrition Research Centre Ireland, School of Health Sciences, Carriganore House, Waterford Institute of Technology published a new study on Mild Cognitive Impairment (MCI) in the Journal of Personalized Medicine  https://www.mdpi.com/2075-4426/10/2/43.

The study is the first of its kind to identify improvements in cognitive performance in individuals with MCI following supplementation with omega-3s, carotenoids and Vitamin E.  

The patients with MCI who received the active intervention [commercially known as Memory Health] exhibited statistically significant improvements in carotenoid concentrations, but also trends in improvements in episodic memory and global cognition were all observed. In contrast, the placebo group remained unchanged or worsened for all measurements.

"Research and science have determined the influence a proper diet has on cognitive functions and brain health. The issue in today's society stems from the lack of nutrients in our food and the poor quality of our diet, thus making science based nutritional supplements like Memory Health A MUST, in our quest for a long, healthy life and retaining our precious memories," said Frederic J. Jouhet, Founder and Co-Manager, Memory Health LLC. 

"Why wait for deterioration or even diagnosis?" added Edward Shehab, Co-Manager of Memory Health. "Science tells us it is never to early to start caring about brain health, but it can be too late. This is scientific evidence that a formulation composed of 1 g of fish oil (of which 430 mg DHA and 90 mg EPA), 10 mg of Lutein, 10 mg of  meso-zeaxanthin and 2 mg of zeaxanthin (the carotenoids), and 15 mg of vitamin E (α-tocopherol) has a tremendous impact on people with Mild Cognitive Impairment. It's real science for real results."

Memory Health is proud to be the sole licensee of a product with such groundbreaking scientific discoveries. These discoveries validate our user experience and the success we are seeing with our growing international network.

About Memory Health LLC:

Memory Health is a Michigan company and a research based, leading group in the nootropic/ brain health supplement space. Memory Health provides a safe, bioavailable and scientifically proven, nutritional supplement based on the Howard Foundation patent granted in the United Kingdom for the prevention and/or treatment of neurodegenerative disease. The Company has agreements with distributors and medical facilities in the USA and Europe and is currently working on agreements with leading chains of Pharmacies and stores.

The patent for invention number GB2568986 

For further information on the company, please visit www.memoryhealth.com 
For further information on the product derived from the patent, please visit www.memoryhealth.com/pages/scientific-research
For further information on the product https://m.youtube.com/watch?v=uw8ixbXmU-g

Statement under the Private Securities Litigation Reform Act:

With the exception of the historical information contained in this release, the matters described herein contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to, product acceptance, the ability to continually obtained increased orders of its products, the ability to meet installation goals, economic, competitive, governmental impacts, whether pending patents will be granted or defendable, validity of intellectual property and patents, the ability to license patents, the ability to commercialize developmental products, as well as technological and/or other factors.

Contacts
Memory Health LLC:
Edward Shehab, Co-Manager 833 863 6679
Frederic Jouhet, Co-Manager  833 863 6679

SOURCE Memory Health LLC

Related Links

https://www.memoryhealth.com

The Lab Report Podcast: Connecting Lab Testing with Personalized Medicine and Optimized Health

The Lab Report is an engaging new podcast series aimed at an innovative approach to exploring personalized medicine, laboratory testing and other fascinating health connections. Hosts, Patti Devers, DO and Michael Chapman, ND, have a natural banter that showcases their energy and enthusiasm for topics that may otherwise be heavy lifting. From leaky gut to functional nutrition and immune support, they have interviewed some of the most recognizable names in functional medicine and the health and wellness arena.

"One of my favorite aspects to the podcast is that it feels as if you were having a conversation with one of your friends about integrative medicine. Whether we are talking to our brilliant guests or just ourselves, we try to deliver the intense science in a way that is enjoyable and easily digestible. We are truly having a blast when we are recording and enjoy sharing that with listeners," said Dr. Chapman.

The Lab Report is presented by Genova Diagnostics to support education for clinicians, patients and industry enthusiasts alike. New podcast episodes post on Tuesdays and Fridays.

Dr. Devers shared, "Although the goal of the podcast is to educate, we try to keep the episodes light and fun. It's easier to learn when you're having a good time. The bonus is that we also happen to be friends, and we love working at Genova."

To learn more or subscribe to The Lab Report, visit www.gdx.net/the-lab-report.

About Genova Diagnostics

Established in 1986, Genova Diagnostics is a leading company in applying a systems-based approach in clinical laboratory testing for the diagnosis, treatment and prevention of complex chronic disease. The internationally renowned lab is committed to the highest standards while improving the lives and well-being of individuals by bringing insights to the complexity of health.

For further information on Genova Diagnostics please visit www.gdx.net.

SOURCE Genova Diagnostics, Inc.

Complementary & Alternative Medicine Market Worth $296.3 Billion by 2027: Grand View Research, Inc.

The global complementary and alternative medicine market size is projected to reach USD 296.3 billion by 2027, exhibiting a CAGR of 19.9%, according to a new report by Grand View Research, Inc. A comparatively high demand for alternative medicine across developing countries and expanding applications of traditional medicine practiced in Asia are two key driving factors of the market. China and India are the key contributors to the Asia Pacific region and thus are offering significant momentum to the revenue generation by complementary and alternative treatment through the study period.

Key suggestions from the report:

• Botanicals are the most ancient form of alternative treatment practices, which include herbal and natural treatment supplements along with another natural form of treatments incorporating oils, herbs, and other curative supplements
• The botanicals intervention segment dominated the global market throughout the study period, whereas magnetic intervention is expected to grow at the fastest rate from 2020 to 2027
• Mind and body healing oriented traditional medicines are some of the most frequently adopted forms of alternate therapies worldwide. Mind and body intervention incorporates various forms of energy and mind exercises to heal ailments
• Yoga has dominated the global complementary and alternative medicine market throughout the study period, whereas hypnotherapy is projected to witness the highest growth rate over the forecast period
• Europe is anticipated to witness highest market share over the forecast period. Rising preference for alternative treatment approaches among patients will drive the regional market for complementary and alternative medicine.
• Key industry participants include Nordic Nutraceuticals, Pure encapsulations, LLC, AYUSH Ayurvedic Pte Ltd, and Sheng Chang Pharmaceutical Company
• Companies are inclined toward strategic partnerships to establish their presence in the market; for instance, in June 2019, AstraZeneca partnered with Luye Pharma Group to market a herbal therapy
• The herbal medicine product is developed from red yeast rice and is formulated to assist patients suffering from cholesterol. With this partnership, AstraZeneca is set to expand its

Read 200 page research report with ToC on "Complementary And Alternative Medicine Market Size, Share & Trends Analysis Report By Intervention (Magnetic Intervention, Energy Healing), By Distribution Method (E-Sales, Direct Sales), By Region, And Segment Forecasts, 2020 - 2027" at: https://www.grandviewresearch.com/industry-analysis/complementary-alternative-medicine-market

In addition, increase in the number of licensed and trained physicians who can offer state-of-the-art complementary therapies is set to boost patient preference toward traditional medicine. It is becoming integral in the healthcare system in Asia, especially in China wherein most of the hospitals in the country have distinct departments and wards that are dedicated to traditional therapeutic approaches.

Moreover, in terms of research, CAM has reached a remunerative stage. This can be attributed to the rising pool of scientists working at established universities across U.S., Europe, and Asia Pacific who are focusing on building a robust foundation for the alternative treatment targeted toward Parkinson's disease, cancer, and diabetes.

Grand View Research has segmented the global complementary and alternative medicine market on the basis of intervention, distribution method, and region:

• Complementary and Alternative Medicine Intervention Outlook (Revenue, USD Billion, 2016 - 2027)
  • Botanicals
    • Ayurveda
    • Naturopathy
    • Homeopathy
  • Acupuncture
  • Mind & Body Healing
    • Yoga
    • Meditation
    • Energy Healing
      • Eden Energy Medicine
      • Others
    • Chakra Healing
    • Hypnotherapy
    • Kinesiology
    • Magnetic Intervention
      • Magnetic Resonance Therapy
      • Bio-magnetic Therapy
• Complementary and Alternative Medicine Distribution Method Outlook (Revenue, USD Billion, 2016 - 2027)
  • Direct Sales
  • E-Sales
  • Distance Correspondence
• Complementary and Alternative Medicine Regional Outlook (Revenue, USD Billion, 2016 - 2027)
  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • Switzerland
    • Austria
    • Spain
    • Norway
    • Denmark
    • Sweden
    • Belgium
    • Netherlands
    • U.K.
    • Ireland
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Hong Kong
    • Singapore
    • New Zealand
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • Israel
    • UAE
    • South Africa

Find more research reports on Pharmaceuticals Industry, by Grand View Research:

• Cold Pain Therapy Market– Rising prevalence of orthopedic diseases and increasing number of sports injuries have led to a high growth of the market.
• Anti-Acne Cosmetics Market– The negative social stigma associated with acne and rising consumption of cosmetics by both men and women, especially from the emerging economies are estimated to drive the growth.
• Cancer Immunotherapy Market– Growing adoption of advanced cancer therapeutic options coupled with rising cancer incidence has been one of the primary growth stimulants for the market

.Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:       Sherry James Corporate Sales Specialist, USA
Grand View Research, Inc.https://www.grandviewresearch.com

Landmark Study Published in Nature Medicine and Presented at the American Society of Nutrition Shows Dietary Inflammation Varies Dramatically Among Healthy Adults, Pointing to the Need for Personalization in Eating

Health science company ZOE announced today the first published results from PREDICT, the largest ongoing nutritional study of its kind. The results, published in Nature Medicine and abstracts shared at the American Society of Nutrition show a wide range of inflammation responses after eating, even amongst apparently healthy people. Dietary inflammation is linked with increased risk for conditions such as heart disease, type 2 diabetes and obesity. The study suggests improved weight management and health could be achieved by eating food that are personalized to reduce dietary inflammation.

ZOE will launch a new test kit and app in July that uses AI to develop personalized eating plans based on a person's unique gut microbes and dietary inflammation. They have launched today a waitlist for customers eager to access the new kit.

"When it comes to weight, we've traditionally put a huge emphasis on factors we have no control over, like genetics," said Tim Spector, MD FRCP FRSB, scientific co-founder of ZOE, senior researcher of the PREDICT study and Professor of Genetic Epidemiology, King's College London, UK. "The fact is, while genetics plays a role, there are many more important factors that impact an individual's response to food and maintenance of a healthy metabolism. This study shows that achieving a healthy weight requires a scientific approach to eating that takes into account an individual's unique biology."

Study Details

Led by Professor Tim Spector and his team at King's College London and ZOE, in collaboration with Massachusetts General Hospital and additional researchers in the US, UK, Italy, Spain and Sweden,* the PREDICT-1 study recruited participants across the UK and the US. This consisted of 1,103 subjects including 660 identical and non-identical twins from the TwinsUK cohort. The study measured a wide range of markers from blood glucose, fat and insulin levels to exercise, sleep and gut bacteria (microbiome).

Every PREDICT participant attended a full hospital day at the start of the study for detailed blood measurements and testing of responses after eating set meals with carefully controlled calorie, fat, protein, carbohydrate and fiber content. They then carried out the rest of the study at home, eating a schedule of set meals and their own free choice of foods.

Participants wore a continuous glucose monitor and activity tracker throughout the duration of the study, took finger prick blood samples to monitor blood fat levels and collected stool samples for microbiome analysis.

Despite wide variation in nutritional responses between participants, results from identical meals eaten on different days showed that individual responses to the same foods were remarkably consistent for each person. Raised levels of blood sugar and blood fat can lead to inflammatory responses via oxidative stress and lipoprotein remodelling.

"When we looked at blood sugar and fat levels across participants who ate the same meal, we could see up to ten times difference in their bodies' response," said Andrew T. Chan, MD, MPH, at Massachusetts General Hospital and Professor at Harvard Medical School. "Many people who would traditionally be viewed as healthy, showed real signs of metabolic stress after eating certain foods. By using AI to predict responses to these meals, we're able to identify a combination of foods for an individual that could reduce potentially harmful inflammatory processes that have been linked to obesity, heart disease, diabetes, fatty liver, and cancer."

PREDICT-1 study results showed:

·       Genetics plays a minor role in determining personal nutritional response and even identical twins can respond very differently to the same foods. This suggests that tests offering personalized nutrition advice based only on genetic information are ineffective.

·       Everyone is unique in the way their bodies respond to eating food (nutritional response), so there is no one "right" way to eat. Traditional standardized diets (e.g., low carb diet, low calorie diet, etc.) and meal plans therefore miss the mark.

·       The optimal time to eat for nutritional health also depends on the individual rather than fixed "perfect" mealtimes. The researchers found that some people clearly metabolized food better at breakfast while others saw no difference. This is the subject of ongoing research.

·       Optimal meal composition in terms of fat, carbohydrates, proteins and fiber (macronutrients) is also highly individual, so prescriptive diets based on fixed macronutrient ratios are too simplistic and will not work for everyone. For example, a sensitive glucose responder may need to reduce carbohydrates whereas someone else may be able to eat these freely.

·       The relationship between the calories consumed in a meal and nutritional response is weak and the form a food is in (cooked, chopped, ground) will produce a drastically different result.

The ZOE plan: Harnessing AI for Better Health

Using this ongoing research, the ZOE team in partnership with scientists around the world has developed a new personalized eating plan that will help you hit your healthiest weight by reducing dietary inflammation and supporting your gut. This is not a diet or calorie restriction plan. The at home test kit is based on the novel tests developed for this study but easy to use and offers insights into your unique gut microbes and dietary inflammation. Once you've tested your body, you'll be given your insights and a personalized program to reduce dietary inflammation and boost healthy gut microbes. ZOE's AI powered app makes following the plan easy and offers personalized scores to a large number of foods, delicious recipes and insights that teach you clever ways to continue to eat the foods you love.

The ZOE plan is currently accepting people to its 20,000 strong waitlist and will be available to early applicants this July. Register to apply here: joinzoe.com/signup.

The company is also the creator of the COVID Symptom Study app, which uses AI and symptom data to predict the spread of COVID-19 in real-time. The app has 4 million users globally, with multiple scientific papers in journals such as Science and Nature Medicine. Data from the COVID Symptom Study app confirms that people who are obese are more likely to end up in hospital with COVID-19. People living with diabetes, cancer and heart disease are also at increased risk of hospitalisation. Public health efforts are increasingly focused on reducing the health impacts of many conditions associated with poor nutrition and being overweight, including COVID-19.

About the PREDICT Studies

The PREDICT (Personalized REsponses to Dietary Composition Trial) studies are the world's largest ongoing program of nutrition research. This program of research exists to understand the role of personalized nutrition and the gut microbiome to solve complex, food related health issues including chronic disease and metabolic syndrome. The studies are led by ZOE in collaboration with researchers and scientists at Massachusetts General Hospital, Harvard Medical School, Stanford Medicine, Tufts University and King's College London.

PREDICT 1: The study included 1,103 U.K. and US participants including identical twins to understand the role of genetics and the microbiome in personal nutrition. Forthcoming scientific papers include findings on the factors that contribute to hunger and energy lulls, and post-meal fat response and its influence on dietary inflammation.

PREDICT 2: Studied 1,100 US participants and recently completed in March 2020. This study included complex microbiome profiling which has led to the discovery of a specific microbe that may determine your ability to metabolize food better. Initial findings will be published later in the year.

The next stage of the PREDICT studies will be announced soon.

About ZOE

ZOE is a health science company using data-driven research to tackle the world's health issues. By using artificial intelligence combined with digital technologies like mobile phones, ZOE enables large-scale scientific studies to tackle issues like COVID-19, dietary inflammation and the impact of nutrition on health.

Located in London and Boston, ZOE was founded by Professor Tim Spector of King's College London, machine learning leader Jonathan Wolf and entrepreneur George Hadjigeorgiou. ZOE has carried out the largest nutritional studies of their kind in the world, runs the COVID Symptom Study app with 4 million users around the world, and was named one of the Deloitte Fast 50 Rising Stars in 2019 for the company's contribution to science enabled by technology and machine learning.

For more information on ZOE's mission and science visit joinzoe.com.